Results 261 to 270 of about 1,206,666 (303)

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Lancet, The, 2020
Kwok-Cheung Lung, Tom Wai-Hin Chung, Hoi-Ping Shum   +2 more
exaly  

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)

Lancet, The, 2002
Mauro Bergui
exaly  

Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-beta-lactamases.

Journal of Medicinal Chemistry, 2010
P. Lassaux, M. Hamel, M. Gulea, H. Delbrück, P. Mercuri, L. Horsfall, D. Dehareng, M. Kupper, J. Frère, Kurt M V Hoffmann, M. Galleni, C. Bebrone   +11 more
semanticscholar   +1 more source

Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes

Cell Metabolism, 2019
Peter J Thompson, Vasilis Ntranos, Mark A Atkinson   +2 more
exaly  

Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-beta-lactamases.

Journal of the American Chemical Society, 2010
J. Johnson, M. Gretes, V. Goodfellow, L. Marrone, M. Heynen, N. Strynadka, G. Dmitrienko   +6 more
semanticscholar   +1 more source

Neutrino–nuclear responses for astro-neutrinos, single beta decays and double beta decays

Physics Reports, 2019
Jouni Suhonen, Kai Zuber
exaly  

Rapid characterization of beta-lactamases by multiplex PCR.

Methods in molecular biology, 2010
N. Woodford
semanticscholar   +1 more source

Beta-Lactamase

2007
openaire   +1 more source

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

New England Journal of Medicine, 2006
Bianca Weinstock-Guttman
exaly  

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

Lancet, The, 2003
Per Soelberg Sørensen, Thor Petersen, Egon Stenager   +2 more
exaly